Susquehanna International Group, LLP Eledon Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 21,788 shares of ELDN stock, worth $54,252. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,788
Previous 99,778
78.16%
Holding current value
$54,252
Previous $205,000
72.2%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ELDN
# of Institutions
33Shares Held
18.3MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$15.7 Million0.51% of portfolio
-
Armistice Capital, LLC New York, NY2.34MShares$5.82 Million0.08% of portfolio
-
Zimmer Partners, LP New York, NY2.11MShares$5.25 Million0.11% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.5MShares$3.74 Million0.03% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.3MShares$3.23 Million0.5% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $34.3M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...